These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12650885)

  • 21. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.
    Rivolta I; Clancy CE; Tateyama M; Liu H; Priori SG; Kass RS
    Physiol Genomics; 2002 Sep; 10(3):191-7. PubMed ID: 12209021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.
    Makita N; Behr E; Shimizu W; Horie M; Sunami A; Crotti L; Schulze-Bahr E; Fukuhara S; Mochizuki N; Makiyama T; Itoh H; Christiansen M; McKeown P; Miyamoto K; Kamakura S; Tsutsui H; Schwartz PJ; George AL; Roden DM
    J Clin Invest; 2008 Jun; 118(6):2219-29. PubMed ID: 18451998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
    Baroudi G; Chahine M
    FEBS Lett; 2000 Dec; 487(2):224-8. PubMed ID: 11150514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
    Vatta M; Ackerman MJ; Ye B; Makielski JC; Ughanze EE; Taylor EW; Tester DJ; Balijepalli RC; Foell JD; Li Z; Kamp TJ; Towbin JA
    Circulation; 2006 Nov; 114(20):2104-12. PubMed ID: 17060380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes.
    Rivolta I; Abriel H; Tateyama M; Liu H; Memmi M; Vardas P; Napolitano C; Priori SG; Kass RS
    J Biol Chem; 2001 Aug; 276(33):30623-30. PubMed ID: 11410597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.
    Huang H; Priori SG; Napolitano C; O'Leary ME; Chahine M
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H288-99. PubMed ID: 21076026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome.
    Riuró H; Campuzano O; Arbelo E; Iglesias A; Batlle M; Pérez-Villa F; Brugada J; Pérez GJ; Scornik FS; Brugada R
    Heart Rhythm; 2014 Jul; 11(7):1202-9. PubMed ID: 24662403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel.
    Surber R; Hensellek S; Prochnau D; Werner GS; Benndorf K; Figulla HR; Zimmer T
    Cardiovasc Res; 2008 Mar; 77(4):740-8. PubMed ID: 18065446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations.
    Wattanasirichaigoon D; Vesely MR; Duggal P; Levine JC; Blume ED; Wolff GS; Edwards SB; Beggs AH
    Am J Med Genet; 1999 Oct; 86(5):470-6. PubMed ID: 10508990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the SCN5A gene: evidence for a link between long QT syndrome and sudden death?
    Kiehne N; Kauferstein S
    Forensic Sci Int Genet; 2007 Jun; 1(2):170-4. PubMed ID: 19083750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The implications of genetic mutations in the sodium channel gene (SCN5A).
    Moric E; Herbert E; Trusz-Gluza M; Filipecki A; Mazurek U; Wilczok T
    Europace; 2003 Oct; 5(4):325-34. PubMed ID: 14753626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations.
    Shinlapawittayatorn K; Du XX; Liu H; Ficker E; Kaufman ES; Deschênes I
    Heart Rhythm; 2011 Mar; 8(3):455-62. PubMed ID: 21109022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired stretch modulation in potentially lethal cardiac sodium channel mutants.
    Banderali U; Juranka PF; Clark RB; Giles WR; Morris CE
    Channels (Austin); 2010; 4(1):12-21. PubMed ID: 20090423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome.
    Smits JP; Veldkamp MW; Bezzina CR; Bhuiyan ZA; Wedekind H; Schulze-Bahr E; Wilde AA
    Cardiovasc Res; 2005 Aug; 67(3):459-66. PubMed ID: 16039271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.
    Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG
    Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single Na(+) channel mutation causing both long-QT and Brugada syndromes.
    Bezzina C; Veldkamp MW; van Den Berg MP; Postma AV; Rook MB; Viersma JW; van Langen IM; Tan-Sindhunata G; Bink-Boelkens MT; van Der Hout AH; Mannens MM; Wilde AA
    Circ Res; 1999 Dec 3-17; 85(12):1206-13. PubMed ID: 10590249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.
    Ackerman MJ; Siu BL; Sturner WQ; Tester DJ; Valdivia CR; Makielski JC; Towbin JA
    JAMA; 2001 Nov; 286(18):2264-9. PubMed ID: 11710892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.